» Articles » PMID: 20204055

Surgical Complications Associated with Fasciectomy for Dupuytren's Disease: a 20-year Review of the English Literature

Overview
Journal Eplasty
Specialty General Surgery
Date 2010 Mar 6
PMID 20204055
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Excisional surgery is the mainstay of treatment of Dupuytren's disease. Although outcomes are generally good, complications are common. The objective of this study was to evaluate intraoperative and postoperative complications associated with fasciectomy for Dupuytren's disease.

Methods: A literature search was conducted to identify published, original research that reported surgical complications associated with fasciectomy from 1988 to 2008. Search results were manually evaluated for relevance. Complication rates according to types of disease (primary or recurrent disease) and according to time (intraoperative vs postoperative) and type were collated.

Results: A total of 143 articles were identified; 41 met inclusion criteria, and of these, 28 reported overall surgical complication rates ranging from 3.6% to 39.1%. Major complications occurred in 15.7%, including digital nerve injury 3.4%, digital artery injury 2%, infection 2.4%, hematoma 2.1%, and complex regional pain syndrome 5.5%. Other common, more minor injuries included flare reaction in 9.9%, wound healing complications in 22.9%, and a range of other complications. In the few (n = 3) studies in which primary and recurrent diseases were directly compared, digital nerve injuries and digital artery injuries were approximately 10 times more common in patients with recurrent disease (20%) than those with primary disease (approximately 2%), though the numbers are too small for statistical significance.

Conclusions: A review of published reports by surgeons shows that surgical fasciectomy for Dupuytren's disease has a high number of complications. Surgeons should be mindful of the potential for intraoperative and postoperative complications and counsel their patients accordingly.

Citing Articles

Experience in the surgical treatment of Dupuytren's disease using WALANT anesthesia.

Ferraguti M, Morano G J Hand Microsurg. 2025; 17(3):100218.

PMID: 40027888 PMC: 11869110. DOI: 10.1016/j.jham.2025.100218.


Therapy for Dupuytren's Disease (II): Collagenase Therapy vs. Limited Fasciectomy-A Long-Term Comparative Study.

Wachtel N, Dingler F, Kuhlmann C, Mert S, Haas-Lutzenberger E, Alt V Life (Basel). 2025; 15(1).

PMID: 39860016 PMC: 11767046. DOI: 10.3390/life15010076.


Percutaneous Needle Fasciotomy Versus Limited Fasciectomy for Dupuytren Disease: A Linear Model Assessment of Short-term Efficacy.

Kwok J, Shtarbanov P, Giwa L, Toft N, Nikkhah D, Kang N Plast Reconstr Surg Glob Open. 2024; 12(11):e6326.

PMID: 39583785 PMC: 11584222. DOI: 10.1097/GOX.0000000000006326.


Collagenase Versus Needle Fasciotomy for Primary Metacarpophalangeal Dupuytren Contracture: Five-Year Results from a Randomized Controlled Trial.

Hauksson I, Havdal M, Saltyte Benth J, Hoelsbrekken S, Randsborg P JB JS Open Access. 2024; 9(4).

PMID: 39569009 PMC: 11573333. DOI: 10.2106/JBJS.OA.24.00038.


Clinical Outcomes of Collagenase Injections in Management of Dupuytren Contracture of the Proximal Interphalangeal Joint.

Dent C, Coutelle N, Moore A, Nester M, Simon P, Nydick J J Hand Surg Glob Online. 2024; 6(5):627-630.

PMID: 39381385 PMC: 11456637. DOI: 10.1016/j.jhsg.2024.05.009.


References
1.
Swartz W, Lalonde D . MOC-PS(SM) CME article: Dupuytren's disease. Plast Reconstr Surg. 2008; 121(4 Suppl):1-10. DOI: 10.1097/01.prs.0000305932.46121.84. View

2.
Hu F, Nystrom A, Ahmed A, Palmquist M, Dopico R, Mossberg I . Mapping of an autosomal dominant gene for Dupuytren's contracture to chromosome 16q in a Swedish family. Clin Genet. 2005; 68(5):424-9. DOI: 10.1111/j.1399-0004.2005.00504.x. View

3.
Benson L, Williams C, Kahle M . Dupuytren's contracture. J Am Acad Orthop Surg. 1998; 6(1):24-35. DOI: 10.5435/00124635-199801000-00003. View

4.
Roush T, Stern P . Results following surgery for recurrent Dupuytren's disease. J Hand Surg Am. 2000; 25(2):291-6. DOI: 10.1053/jhsu.2000.jhsu25a0291. View

5.
Smith A . Diagnosis and indications for surgical treatment. Hand Clin. 1991; 7(4):635-42; discussion 643. View